In this study, we used sphere cultures in vitro, and tumor formation in mice, to successfully validate the self-renewal and tumor-initiating capacity of CD44+HER2+ GCSCs from primary gastric tumors. This evidence concerns the gene CD44 and gastric neoplasm.